Prevention of injury-induced suppression of T-cell immunity by the Cd1d/NKT cell-specific ligand α-galactosylceramide

Shock

Volumn 29, Issue 2, 2008, Pages 269-277

  Tulley, Julia M ^a   Palmer, Jessica L ^a   Gamelli, Richard L ^a   Faunce, Douglas E ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Burns; CD1d; Delayed type hypersensitivity; Immune suppression; Natural killer T cells

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACCIDENT PREVENTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BURN; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INNATE IMMUNITY; LIGAND BINDING; MALE; MORBIDITY; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NATURAL KILLER T CELL; NONHUMAN; RISK FACTOR; SEPSIS; SPLEEN CELL;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD40; BURNS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 38349126705     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31811ff60c     Document Type: Article

References (50)

1. American Burn Association: National Burn Repository: 2002 Report. Chicago, IL: American Burn Association, 2002.
2. Guo Z, Kavanagh E, Zang Y, Dolan SM, Kriynovich SJ, Mannick JA, Lederer JA: Burn injury promotes antigen-driven Th2-type responses in vivo. J Immunol 171:3983-3990, 2003.
3. Kavanagh EG, Kelly JL, Lyons A, Soberg CC, Mannick JA, Lederer JA: Burn injury primes naive CD4+ T cells for an augmented T-helper 1 response. Surgery 124:269-276, 1998.
4. Kelly JL, O'Suilleabhain CB, Soberg CC, Mannick JA, Lederer JA: Severe injury triggers antigen-specific T-helper cell dysfunction. Shock 12:39-45, 1999.
5. Mannick JA, Rodrick ML, Lederer JA: The immunologic response to injury. J Am Coll Surg 193:237-244, 2001.
6. Gamelli RL, He LK, Liu LH: Macrophage mediated suppression of granulocyte and macrophage growth after burn wound infection reversal by means of anti-PGE2. J Burn Care Rehab 21:64-69, 2000.
7. Gamelli RL, He LK, Liu H: Macrophage suppression of granulocyte and macrophage growth following burn wound infection. J Trauma Inj Infect Crit Care 37:888-892, 1994.
8. Santangelo S, Gamelli RL, Shankar R: Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg 233:97-106, 2001.
9. Silva KD, Gamelli RL, Shankar R: Bone marrow stem cell and progenitor response to injury. Wound Rep Regen 9:495-500, 2001.
10. Dries DJ, Lorenz K, Kovacs EJ: Differential neutrophil traffic in gut and lung after scald injury. J Burn Care Rehab 22:203-209, 2001.
11. Durbin EA, Gregory MS, Messingham KA, Fontanilla CV, Duffner LA, Kovacs EJ: The role of interleukin 6 in interferon-gamma production in thermally injured mice. Cytokine 12:1669-1675, 2000.
12. Faunce DE, Llanas JN, Patel PJ, Gregory MS, Duffner LA, Kovacs EJ: Neutrophil chemokine production in the skin following scald injury. Burns 25:403-410, 1999.
13. el-Ahmed S, el-Shahat AS, Saad SO: Assessment of certain neutrophil receptors, opsonophagocytosis and soluble intercellular adhesion molecule-1 (ICAM-1) following thermal injury. Burns 25:395-401, 1999.
14. Faunce DE, Gamelli RL, Kovacs EJ: A role for CD1d-NKT cells in injury-associated T cell suppression. J Leukoc Biol 73:747-755, 2003.
15. Palmer JL, Tulley JM, Kovacs EJ, Gamelli RL, Taniguchi M, Faunce DE: Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells. J Immunol 177:92-99, 2006.
16. Guo Z, Kavanagh E, Zang Y, Dolan SM, Kriynovich SJ, Mannick JA, Lederer JA: Burn injury promotes antigen-driven Th2-type responses in vivo. J Immunol 171:3983-3990, 2003.
17. Toth B, Alexander M, Daniel T, Chaudry IH, Hubbard WJ, Schwacha MG: The role of γδ T-cells in the regulation of neutrophil-mediated tissue damage after thermal injury. J Leukoc Biol 76:545-552, 2004.
18. Choileain NN, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA: Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 176:225-236, 2006.
19. MacConmara M, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak P, Rogers S, Lederer JA, Mannick JA: Increased CD4+CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 244:514-523, 2006.
20. Murphy TJ, Choileain NN, Zang Y, Mannick JA, Lederer JA: CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 174:2957-2963, 2005.
21. Gumperz JE, Miyake S, Yamamura T, Brenner MB: Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195:625-636, 2002.
22. Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI: Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99:1259-1266, 2002.
23. Gillessen S, Naumov YN, Nieuwenhuis EE, Exley MA, Lee FS, Mach N, Luster AD, Blumberg RS, Taniguchi M, Balk SP, et al.: CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc Natl Acad Sci U S A 100:8874-8879, 2003.
24. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D: Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16:583-594, 2002.
25. Skold M, Behar SM: Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun 71:5447-5455, 2003.
26. Gumperz JE, Brenner MB: CD1-specific T cells in microbial immunity. Curr Opin Immunol 13:471-478, 2001.
27. Walker HL, Mason AD: A standard animal burn. J Trauma 8:1049-1054, 1968.
28. Faunce DE, Gregory MS, Kovacs EJ: Effects of acute ethanol exposure on cellular immune responses in a murine model of thermal injury. J Leukoc Biol 62:733-740, 1997.
29. Spector WS (ed.): Handbook of Biological Data. Philadelphia, PA: Saunders Publishing, p 157, 1956.
30. Faunce DE, Gamelli RL, Kovacs EJ: A role for CD1d-NKT cells in injury-associated T cell suppression. J Leukoc Biol 73:747-755, 2003.
31. Faunce DE, Stein-Streilein J: NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 169:31-38, 2002.
32. Faunce DE, Sonoda KH, Stein-Streilein J: MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 166:313-321, 2001.
33. Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI: NKT cells - conductors of tumor immunity? Curr Opin Immunol 14:165-171, 2002.
34. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-490, 1995.
35. O'Sullivan ST, O'Connor TP: Immunosuppression following thermal injury: the pathogenesis of immunodysfunction. Br J Plast Surg 50:615-623, 1997.
36. Sullivan BA, Kronenberg M: Activation or anergy: NKT cells are stunned by alpha-galactosylceramide. J Clin Invest 115:2328-2329, 2005.
37. Parekh VV, Wilson MT, Olivares-Villagomez D, Singh AK, Wu L, Wang C-R, Joyce S, Van Kaer L: Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 115:2572-2583, 2005.
38. Wilson MT, Johansson C, Olsen KR, Singh AK, Stanic AK, Wang C-R, Joyce S, Wick MJ, Van Kaer L: The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Nat Acad Sci U S A 100:10913-10918, 2003.
39. Harada M, Ken-ichiro S, Wakao H, Sakata S, Ishizuka Y, Ito T, Kojo S, Nakayama T, Taniguchi M: Down-regulation of the invariant Va14 antigen receptor in NKT cells upon activation. Int Immunol 16:241-247, 2004.
40. Carnaud C, Lee D, Donnars O, Park S-H, Beavis A, Koezuka Y, Bendelac A: Cutting Edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163:4647-4650, 1999.
41. Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K: Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur J Immunol 31:1720-1727, 2001.
42. Motohashi S, Ishikawa A, Ishikawa E, Otsuji M, Iizasa T, Hanaoka H, Shimizu N, Horiguchi S, Okamoto Y, Fujii S, et al.: A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 12:6079-6086, 2006.
43. Apostolou I, Takahama Y, Belmant C, Kawano T, Muerre M, Marchal G, Cui J, Taniguchi M, Nakauchi H, Fournie JJ, et al.: Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A 96:5141-5146, 1999.
44. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB: Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4:1230-1237, 2003.
45. Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K, Abraham R, Juji T, Macfarlane DJ, Nicol AJ: Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103:383-389, 2004.
46. Nieuwenhuis EES, Matsumoto T, Exley MA, Schleipman RA, Glickman J, Bailey DT, Corazza N, Colgan SP, Onderdonk AB, Blumberg RS: CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 8:588-593, 2002.
47. Roberts TJ, Lin Y, Spence PM, Van Kaer L, Brutkiewicz RR: CD1d1-dependent control of the magnitude of an acute antiviral immune response. J Immunol 172:3454-3461, 2004.
48. Dieli FD, Sireci G, Russo D, Taniguchi M, Ivanyi J, Fernandez C, Troye-Blomberg M, De Leo G, Salerno A: Resistance of natural killer T cell-deficient mice to systemic Shwartzman Reaction. J Exp Med 192:1645-1651, 2000.
49. Rhee RJ, Carlton S, Lomas JL, Lane C, Brossay L, Cioffi WG, Ayala A: Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction. J Surg Res 115:74-81, 2003.
50. Kawakami K, Yamamoto N, Kinjo Y, Miyagi K, Nakasone C, Uezu K, Kinjo T, Nakayama T, Taniguchi M, Saito A: Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 33:3322-3330, 2003.